SSY Group Limited

SSY Group Limited operates as an investment holding entity primarily engaged in the pharmaceutical sector. The company's core operations encompass the research, development, production, and distribution of a diverse array of pharmaceutical goods, supplied to hospitals and distributors across the People's Republic of China and international markets. Its extensive product portfolio features various intravenous (IV) infusion solutions, such as non-PVC soft bags, upright soft bags, plastic and glass bottles, and ampoule injections. Additionally, SSY Group manufactures small volume injectable drugs, oral medications, traditional Chinese medicine formulations, biological preparations, bulk pharmaceutical ingredients, and medical supplies. Beyond its pharmaceutical manufacturing, the group is also involved in pharmaceutical technology research, development, and advisory services, as well as logistics for healthcare products. Intriguingly, the company also maintains operations in the food, beverage, and catering industries. Many of its offerings are marketed under the 'Shimen' brand. Founded in 2004, SSY Group Limited maintains its corporate headquarters in Wanchai, Hong Kong. The company underwent a name change from Lijun International Pharmaceutical (Holding) Co., Ltd. to its current designation in May 2015. Ultimately, SSY Group functions as a subsidiary of China Pharmaceutical Co., Ltd.

CEO: Jiguang Qu - https://www.ssygroup.com.hk